We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+7.91%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$13.3B
AUM Growth
+$802M
Cap. Flow
-$35.2M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.63%
Holding
2,246
New
164
Increased
893
Reduced
982
Closed
190

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Financials 10.11%
3 Healthcare 10%
4 Consumer Discretionary 8.02%
5 Industrials 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCO icon
1651
Ducommun
DCO
$2.89B
$429K ﹤0.01%
+8,492
New +$391K
ONTO icon
1652
Onto Innovation
ONTO
$14.3B
$425K ﹤0.01%
11,634
-16,351
-58% -$555K
VRS
1653
DELISTED
Verso Corporation
VRS
$425K ﹤0.01%
23,585
ABEV icon
1654
Ambev
ABEV
$47B
$423K ﹤0.01%
90,717
-11,524
-11% -$51.1K
AWF
1655
AllianceBernstein Global High Income Fund
AWF
$877M
$423K ﹤0.01%
34,905
-480
-1% -$5.76K
PBI icon
1656
Pitney Bowes
PBI
$2.52B
$423K ﹤0.01%
104,792
-79,084
-43% -$363K
PENN icon
1657
PENN Entertainment
PENN
$2.68B
$423K ﹤0.01%
+16,563
New +$368K
ARLP icon
1658
Alliance Resource Partners
ARLP
$3.31B
$422K ﹤0.01%
39,027
-5,992
-13% -$71.9K
S
1659
DELISTED
Sprint Corporation
S
$422K ﹤0.01%
80,960
+12,332
+18% +$72.3K
EDD
1660
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$380M
$421K ﹤0.01%
60,254
-8,141
-12% -$55.9K
HQL
1661
abrdn Life Sciences Investors
HQL
$599M
$419K ﹤0.01%
24,055
+7,370
+44% +$121K
AMN icon
1662
AMN Healthcare
AMN
$1.29B
$418K ﹤0.01%
6,710
-998
-13% -$59K
EQNR icon
1663
Equinor
EQNR
$93.1B
$418K ﹤0.01%
20,984
+7,242
+53% +$137K
FNF icon
1664
Fidelity National Financial
FNF
$13.9B
$418K ﹤0.01%
9,573
-817
-8% -$36.3K
MCFT icon
1665
MasterCraft Boat Holdings
MCFT
$608M
$416K ﹤0.01%
26,423
TRIP icon
1666
TripAdvisor
TRIP
$1.67B
$416K ﹤0.01%
13,698
-22,432
-62% -$755K
W icon
1667
Wayfair
W
$15.3B
$416K ﹤0.01%
4,605
-595
-11% -$55.5K
MCR
1668
DELISTED
MFS Charter Income Trust
MCR
$414K ﹤0.01%
49,129
-372
-0.8% -$3.1K
SPNT icon
1669
SiriusPoint
SPNT
$2.78B
$414K ﹤0.01%
39,370
-10,243
-21% -$99.5K
VET icon
1670
Vermilion Energy
VET
$1.69B
$412K ﹤0.01%
25,198
-1
-0% -$15
FFIN icon
1671
First Financial Bankshares
FFIN
$5.09B
$411K ﹤0.01%
11,699
-12,722
-52% -$438K
TDOC icon
1672
Teladoc Health
TDOC
$1.22B
$409K ﹤0.01%
4,884
+317
+7% +$24.1K
TM icon
1673
Toyota
TM
$224B
$409K ﹤0.01%
2,913
-426
-13% -$59.5K
WING icon
1674
Wingstop
WING
$3.31B
$407K ﹤0.01%
4,718
+801
+20% +$66.5K
CIT
1675
DELISTED
CIT Group Inc.
CIT
$406K ﹤0.01%
8,901
-20,489
-70% -$918K

Similar funds

Guggenheim Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Guggenheim Capital held 2,246 positions worth $13.3B, up 6.4% from $12.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Guggenheim Capital's Q4 2019 filing shows 164 new, 893 increased, 982 reduced and 190 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 296,002 shares worth $95.7M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $90.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q4 2019 buy was iShares Core S&P 500 ETF: 296,002 shares worth $95.7M.
  • Guggenheim Capital added most to iShares Core US Aggregate Bond ETF in Q4 2019, an estimated $251M increase.
  • Guggenheim Capital's biggest Q4 2019 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $90.9M.
  • Guggenheim Capital fully exited Celgene Corp in Q4 2019, selling an estimated $33.4M.
  • Guggenheim Capital's ten largest holdings make up 13% of its $13.3B portfolio in Q4 2019.
  • Guggenheim Capital opened 164 new positions and closed 190 in Q4 2019.
  • Guggenheim Capital's portfolio value rose 6.4% quarter-over-quarter to $13.3B.

Based on Guggenheim Capital's 13F filing for Q4 2019, filed 14 Feb 2020.